Open-label Placebo in Manual Therapy
1 other identifier
interventional
31
1 country
1
Brief Summary
to investigate the effects of placebo in patients affected by low-back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Feb 2024
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 26, 2024
CompletedFirst Submitted
Initial submission to the registry
February 29, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2025
CompletedAugust 11, 2025
March 1, 2024
1.3 years
February 29, 2024
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Numeric Rating Scale
a verbal determination of a pain level on a scale from 0 to 10, in which 0 represents no pain and 10 represents excruciating pain.
Change from baseline of numeric rating scale at week 2, 4 and 8.
Adverse effects
Number and types of adverse effects occurred after intervention
through study completion (8 weeks)
Secondary Outcomes (3)
Change in measures of Von Frey filaments
from baseline at week 2,4 and 8.
Changes in algometer measurements
from baseline at week 2, 4 and 8
Use of analgesics
The week before the scheduled visit.
Study Arms (3)
OMT
ACTIVE COMPARATORParticipants will receive manual treatments. The treatment will include soft-tissue, joint mobilization techniques of the lumbar and sacral region. The treatment will also include the approach of the abdomen and lower limb with the same type of techniques. Four treatments will be provided at 1, 2, 4 and 8 weeks.
Open-label placebo
EXPERIMENTALThis group will receive an open-label placebo. The manual treatment will be performed in the same areas of the active comparator but using a very light pressure. Additionally, before the start of the treatment, Four treatments will be provided at 1, 2, 4 and 8 weeks.
Waiting list
NO INTERVENTIONParticipants will receive no treatment.
Interventions
Eligibility Criteria
You may qualify if:
- Adult patients (+18 years) who complain of chronic non-specific low back pain for at least 3 months with or without pain exacerbations at the time of recruitment, will be included.
- Patients will need to have a diagnosis of low back pain made by a physician
You may not qualify if:
- pathologies such as ankylosing spondylitis, infections, fractures, tumors or metastases.
- Pregnant women
- patients with previous spinal surgery or undergoing cortisone therapy in the 6 months prior to the trial
- diseases that may affect the interpretation of results such as fibromyalgia
- patients currently being treated by other specialists or other manual therapists
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CTFO
Saronno, Varese, 21047, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 29, 2024
First Posted
March 12, 2024
Study Start
February 26, 2024
Primary Completion
June 18, 2025
Study Completion
June 18, 2025
Last Updated
August 11, 2025
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share